CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone.
Saved in:
| Title: | CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone. |
|---|---|
| Authors: | Wasan, H. S.1 wasan@cancer.org.uk, Springett, G. M.2, Chodkiewicz, C.2, Wong, R.3, Maurel, J.4, Barone, C.5, Rosbrook, B.6, Ricart, A. D.6, Kim, S.6, Spano, J.-P.7 |
| Source: | British Journal of Cancer. 10/12/2009, Vol. 101 Issue 7, p1162-1167. 6p. 3 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/sj.bjc.6605243 |
